Freedom of Information request on the UK Public Assessment Report for the COVID-19 vaccine Pfizer/BioNTech (FOI 21/1158)
Published 26 May 2022
© Crown copyright 2022
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-1-november-2021/freedom-of-information-request-on-the-uk-public-assessment-report-for-the-covid-19-vaccine-pfizerbiontech-foi-211158
FOI 21/1158
3rd November 2021
Dear,
Thank you for your request.
I note that you refer to the UK Public Assessment Report for the COVID-19 vaccine Pfizer/BioNTech in your email. This document details the data submitted to support the application, and provides an overview of the assessment of the COVID-19 vaccine Pfizer/BioNTech with confidential information removed. In essence, it is the end product of the considerations of the assessment team and advice of the Expert Working Groups and the Commission on Human Medicines (CHM).
The summary minutes for the CHM meetings can be found at the following link: Commission on Human Medicines and Expert Advisory Group Final Summary Minutes Powered by Box
Kind regards,
MHRA Customer Service Centre
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 020 3080 6000